Meta-analysis: Allopurinol in the prevention of postendoscopic retrograde cholangiopancreatography pancreatitis

Alimentary Pharmacology and Therapeutics

Volumn 28, Issue 5, 2008, Pages 557-564

  Bai, Y ^a   Gao, J ^a   Zhang, W ^a   Zou, D ^a   Li, Z ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMYLASE; TRIACYLGLYCEROL LIPASE;

ABDOMINAL PAIN; AMYLASE BLOOD LEVEL; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG MEGADOSE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; INCIDENCE; LOW DRUG DOSE; META ANALYSIS; PANCREATITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ACUTE DISEASE; ALLOPURINOL; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; MALE; PANCREATITIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TREATMENT OUTCOME;

EID: 48449087716     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03756.x     Document Type: Article

References (34)

1. Tsujino T, Isayama H, Komatsu Y, et al. Risk factors for pancreatitis in patients with common bile duct stones managed by endoscopic papillary balloon dilation. Am J Gastroenterol 2005 100 : 38 42.
2. Masci E, Toti G, Mariani A, et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 2001 96 : 417 23.
3. Loperfido S, Angelini G, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998 48 : 1 10.
4. Freeman ML, DiSario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 2001 54 : 425 34.
5. Andriulli A, Loperfido S, Napolitano G, et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol 2007 102 : 1781 8.
6. Andriulli A, Leandro G, Federici T, et al. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis. Gastrointest Endosc 2007 65 : 624 32.
7. Bai Y, Gao J, Zou DW, et al. Prophylactic octreotide administration does not prevent post-ERCP pancreatitis: a meta-analysis of randomized controlled trials. Pancreas 2008, in press.
8. Broe PJ, Cameron JL. Experimental gallstone pancreatitis: pathogenesis and response to different treatment modalities. Ann Surg 1982 195 : 566 73.
9. Sanfey H, Cameron JL. Increased permeability: an early lesion in acute pancreatitis. Ann Surg 1984 200 : 405 13.
10. Sanfey H, Bulkley G, Cameron JL. Pathogenesis of acute pancreatitis: role of oxygen-derived free radicals in the pathogenesis. Surg Forum 1983 33 : 222 4.
11. Clemens JA, Bulkley GB, Cameron JL, et al. Effect of xanthine oxidase inhibition with allopurinol on the incidence and severity of post-ERCP pancreatitis and hyperamylasemia in a prospective, randomized, double-blind, placebo-controlled clinical trial of 168 patients [abstract]. Gastroenterology 1991 100 : A270.
12. Budzyńska A, Marek T, Nowak A, et al. A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis. Endoscopy 2001 33 : 766 72.
13. Katsinelos P, Kountouras J, Chatzis J, et al. High-dose allopurinol for prevention of post-ERCP pancreatitis: a prospective randomized double-blind controlled trial. Gastrointest Endosc 2005 61 : 407 15.
14. Mosler P, Sherman S, Marks J, et al. Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis. Gastrointest Endosc 2005 62 : 245 50.
15. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995 273 : 408 12.
16. Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses Lancet 1998 352 : 609 13.
17. Higgins JPT, Green S, editors. Assessment of study quality. Cochrane handbook for systematic reviews of interventions 4.2.5 [updated May 2005]; Section 6. In : The Cochrane Library, Issue 3. Chichester, UK : John Wiley & Sons, Ltd, 2005.
18. Bai Y, Gao J, Zou DW, et al. Prophylactic antibiotics can not reduce infected pancreatic necrosis and mortality in acute necrotizing pancreatitis: evidence from a meta-analysis of randomized controlled trials. Am J Gastroenterol 2008 103 : 104 10.
19. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986 7 : 177 88.
20. Berlin JA, Laird NM, Sacks HS, et al. A comparison of statistical methods for combining event rates from clinical trials. Stat Med 1989 8 : 141 51.
21. Higgins JP, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med 2002 21 : 1539 58.
22. Egger M, Davey Smith G, Schneider M, et al. Bias in metaanalysis detected by a simple, graphical test. Br Med J 1997 315 : 629 34.
23. Badra G, Galal AS, Rowaisha I, et al. Allopurinol vs octreotide in the prevention of post-ERCP pancreatitis in patients with biliary obstruction. A randomized controlled trial. Am J Gastroenterol 2000 95 : 2488.
24. Romagnuolo J, Bailey RJ, Mortimer ST, et al. Allopurinol in the prevention of ERCP pancreatitis: preliminary results from a randomized double-blind placebo-controlled trial. Can J Gastroenterol 2001 15 : 43A.
25. Romagnuolo J, Hilsden R, Sandha GS, et al. Allopurinol to prevent pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized placebo-controlled trial. Clin Gastroenterol Hepatol 2008 6 : 465 71.
26. Zheng M, Bai J, Yuan B, et al. Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitis. BMC Gastroenterol 2008 8 : 6.
27. Sanfey H, Bulkley GB, Cameron JL. The pathogenesis of acute pancreatitis. The source and role of oxygen-derived free radicals in three different experimental models. Ann Surg 1985 201 : 633 9.
28. Nordback IH, Cameron JL. The mechanism of conversion of xanthine dehydrogenase to xanthine oxidase in acute pancreatitis in the canine isolated pancreas preparation. Surgery 1993 113 : 90 7.
29. Lambert PC, Sutton AJ, Abrams KR, et al. A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. J Clin Epidemiol 2002 55 : 86 94.
30. Berlin JA, Santanna J, Schmid CH, et al. Individual patient- versus group-level data meta-regressions for the investigation of treatment effects modifiers: ecological bias rears its ugly head. Stat Med 2002 21 : 371 87.
31. Higgins JPT, Thompson SG. Controlling the risk of spurious findings from meta-regression. Stat Med 2004 23 : 1663 82.
32. Cheng CL, Sherman S, Watkins JL, et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol 2006 101 : 139 47.
33. Halpern S, Karlawish JH, Berlin JA. The continuing unethical conduct of underpowered clinical trials. JAMA 2002 288 : 358 62.
34. Janosky JE. The ethics of underpowered clinical trials. JAMA 2002 288 : 2118 9.